Literature DB >> 22899672

IgGs containing light chains of the λ- and κ- type and of all subclasses (IgG1-IgG4) from the sera of patients with systemic lupus erythematosus hydrolyze myelin basic protein.

Anna M Bezuglova1, Ludmila P Konenkova, Valentina N Buneva, Georgy A Nevinsky.   

Abstract

Human myelin basic protein (hMBP)-hydrolyzing activity was recently shown to be an intrinsic property of antibodies from systemic lupus erythematosus (SLE) patients. Here, we present the first evidence demonstrating a significant diversity of different fractions of polyclonal IgGs (pIgGs) from SLE patients in their affinity for hMBP and in the ability of pIgGs to hydrolyze hMBP at different optimal pH values (5.3-9.5); the pH profiles of IgG1, IgG2, IgG3 and IgG4 were unique. IgGs containing the λ-type of light chains demonstrated higher relative activities (RAs) in the hydrolysis of hMBP and its oligopeptides (OPs) than κ-IgGs. IgGs of all four subclasses were catalytically active; their RAs in the hydrolysis of hMBP increased in the following order: IgG4 < IgG2 < IgG3 < IgG1. Metal-dependent proteolytic activity of λ-IgG, IgG1, IgG2 and IgG3 was higher than their serine protease-like activity, while these activities of κ-IgG were comparable. Phenylmethylsulfonylfluoride had almost no effect on the activity of IgG4, while EDTA significantly suppressed its activity. The RAs of λ-IgG in the hydrolysis of four OPs corresponding to different cleavage sites of hMBP were remarkably higher than those for κ-IgGs. IgG1-IgG4 demonstrated different RAs and patterns of hydrolysis of these four OPs. Although combination of Ca²⁺ plus Mg²⁺ was the best in the activation of IgG1 and IgG2, IgG3 and IgG4 demonstrated the highest activity in the presence of Ca²⁺ plus Co²⁺. The ratio of the RAs of λ-IgG, κ-IgG and IgG1-IgG4 preparations in all analyzed cases was individual for each preparation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899672     DOI: 10.1093/intimm/dxs071

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

1.  Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Visilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

2.  Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

3.  Changes in cell differentiation and proliferation lead to production of abzymes in EAE mice treated with DNA-Histone complexes.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergey E Sedykh; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2018-09-28       Impact factor: 5.310

4.  Diagnostics of autoimmune neurodegeneration using fluorescent probing.

Authors:  Yakov Lomakin; Anna Kudriaeva; Nikita Kostin; Stanislav Terekhov; Alena Kaminskaya; Alexander Chernov; Maria Zakharova; Maria Ivanova; Taras Simaniv; Georgy Telegin; Alexander Gabibov; Alexey Belogurov
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

5.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Taisiya A Parkhomenko; Pavel S Dmitrenok; Nina M Krotenko; Nikolai S Fattakhov; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Open Biol       Date:  2015-09       Impact factor: 6.411

6.  Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.

Authors:  Vasilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Edward Cesnik; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

7.  Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities.

Authors:  Anna S Tolmacheva; Evgeny A Ermakov; Valentina N Buneva; Georgy A Nevinsky
Journal:  R Soc Open Sci       Date:  2018-01-31       Impact factor: 2.963

8.  Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.

Authors:  Evgeny A Ermakov; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

9.  Production of Abzymes in Th, CBA, and C57BL/6 Mice before and after MOG Treatment: Comparing Changes in Cell Differentiation and Proliferation.

Authors:  Kseniya S Aulova; Andrey E Urusov; Ludmila B Toporkova; Sergey E Sedykh; Yuliya A Shevchenko; Valery P Tereshchenko; Sergei V Sennikov; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  Biomolecules       Date:  2019-12-28

10.  IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs.

Authors:  Evgeny A Ermakov; Evelina M Kabirova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.